Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
Clinical trial NCT05997277 · TERMINATED
Trial details
- NCT number
- NCT05997277
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2025-02-25
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.